{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:13:29Z","timestamp":1777396409100,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.euf.2024.05.006","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T11:25:17Z","timestamp":1722684317000},"page":"377-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mini-review: Evaluation and Management of Retroperitoneal Masses in Patients with Testicular Cancer"],"prefix":"10.1016","volume":"10","author":[{"given":"Xinyan","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingqiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Chin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravindran","family":"Kanesvaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2024.05.006_b0005","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1200\/JCO.2004.07.188","article-title":"2-18Fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial","volume":"22","author":"De Santis","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2024.05.006_b0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/annonc\/mdr052","article-title":"2-18Fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial","volume":"23","author":"Bachner","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euf.2024.05.006_b0015","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1200\/JCO.18.00210","article-title":"Questioning the value of fluorodeoxyglucose positron emission tomography for residual lesions after chemotherapy for metastatic seminoma: results of an international global germ cell cancer group registry","volume":"36","author":"Cathomas","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2024.05.006_b0020","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/14737140.2019.1580146","article-title":"Management of residual masses in testicular germ cell tumors","volume":"19","author":"Heidenreich","year":"2019","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.euf.2024.05.006_b0025","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1200\/JCO.2008.17.1157","article-title":"[18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German Multicenter Positron Emission Tomography Study Group","volume":"26","author":"Oechsle","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2024.05.006_b0030","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.1200\/JCO.2007.13.6283","article-title":"Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors","volume":"25","author":"Carver","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2024.05.006_b0035","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/JU.0000000000001960","article-title":"Percentage of teratoma in orchiectomy and risk of retroperitoneal teratoma at the time of postchemotherapy retroperitoneal lymph node dissection in germ cell tumors","volume":"206","author":"Calaway","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2024.05.006_b0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.urology.2011.09.038","article-title":"Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancer","volume":"79","author":"Masterson","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.euf.2024.05.006_b0045","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.athoracsur.2010.12.034","article-title":"Survival after resection for metastatic testicular nonseminomatous germ cell cancer to the lung or mediastinum","volume":"91","author":"Kesler","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.euf.2024.05.006_b0050","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/1097-0142(20010801)92:3<578::AID-CNCR1357>3.0.CO;2-C","article-title":"Multimodality treatment of patients with liver metastases from germ cell tumors: the role of surgery","volume":"92","author":"Rivoire","year":"2001","journal-title":"Cancer"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456924000695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456924000695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T09:42:03Z","timestamp":1731750123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456924000695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2405456924000695"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2024.05.006","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mini-review: Evaluation and Management of Retroperitoneal Masses in Patients with Testicular Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2024.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}